How has been the historical performance of Fermenta Biotec.?

Answer:The historical performance of Fermenta Biotec shows a fluctuating trend over the years, with significant changes in net sales, profits, and overall financial health.

Breakdown:
Fermenta Biotec's net sales increased from 335.66 Cr in Mar'24 to 469.48 Cr in Mar'25, marking a notable recovery from previous years. The total operating income followed a similar trend, rising to 469.48 Cr in Mar'25 from 335.66 Cr in Mar'24. However, total expenditure also increased, reaching 359.68 Cr in Mar'25, up from 308.15 Cr in Mar'24. This led to an operating profit (PBDIT) of 121.62 Cr in Mar'25, a substantial increase from 39.32 Cr in the previous year. Profit before tax turned positive at 83.21 Cr in Mar'25, compared to a loss of 9.87 Cr in Mar'24, resulting in a profit after tax of 76.40 Cr, a significant turnaround from the loss of 24.01 Cr in Mar'24. The company's total assets increased to 585.83 Cr in Mar'25 from 525.83 Cr in Mar'24, while total liabilities also rose to 585.83 Cr from 525.83 Cr, indicating a stable financial position. Cash flow from operating activities decreased to 40.00 Cr in Mar'25 from 105.00 Cr in Mar'24, contributing to a net cash outflow of 10.00 Cr in Mar'25. Overall, the company has shown signs of recovery in its financial performance, particularly in sales and profitability.